The combination of molecular diagnostic technologies is increasingly used to overcome limitations on sensitivity, specificity or multiplexing capabilities, and provide efficient lab-on-chip devices. Two such techniques, PCR amplification and microarray hybridization are used serially to take advantage of the 30 high sensitivity and specificity of the former combined with high multiplexing capacities of the latter.
Introduction
Since the invention of PCR, research in the field of nucleic acid detection technologies has progressed tremendously, allowing for rapid and precise identification of genetic targets. These technologies have resulted in significant advances in infectious disease diagnostics, epidemiology, food safety, and biothreats detection 1, 2 . The use of molecular biology methods in biomedical applications has led to 55 improvements in both the management of patients and their health outcome. Nucleic acid detection methods, mainly in human genetics and for infectious diseases, accelerate the detection and/or identification of genetic biomarkers or targets and improve the chances of patient survival 3, 4 .
Nucleic acids amplification tests are important tools enabling sensitive, specific, and rapid detection of 60 genetic targets 5 . Of these techniques, real-time polymerase chain reaction (rtPCR) is the basis for a majority of molecular assays 6 . However, the usefulness of rtPCR can be limited by the specificity of primers and probes, and also by the genetic variability and number of targets that can be simultaneously detected and identified in a single reaction (typically no more than six) due to overlap of fluorescence spectra [3] [4] [5] 7 .
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The number of targets detected and identified can be increased by hybridizing multiplex PCR amplicons onto an array of capture probes 6, 8 . Microarrays are a preferred method for the detection of multiple targets and these tools are expected to become a significant part of clinical diagnostic testing in the future along with next generation nucleotide sequencing methods 9, 10 . A major limitation hampering 70 the implementation of microarrays in clinical setups derives from complex workflow, requiring numerous steps from sample to results 5, 11 . Furthermore, PCR produces double-stranded DNA targets requiring denaturation or preferably digestion of the complementary strand prior to hybridization onto capture probes immobilized on a solid support 12, 13 . The number of nucleotides in microarray targets is directly correlated with the time to reach hybridization equilibrium. Failure to reach equilibrium 75 results in a stochastic distribution of targets on capture probes leading to variability and reproducibility issues 14 . Thus, for rapid and reproducible hybridizations, short targets are desirable. Furthermore, microarray probe design is dependent of the target DNA sequence which can result in crosshybridization with closely related microorganisms 15, 16 , not predictable by existing models 17, 18 .
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The integration of PCR and microarray technologies onto a microfluidic device is desirable to take advantage of each technique while enabling the automation of these complex processes 19 . However, these technologies generally require separate steps due to specific reagents and conditions 5, 11 . This requires separate liquid handling and reaction chambers resulting in complex design and manufacturing of the device, thereby complicating low-cost integration.
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Real-time PCR has become a standard method in the field of molecular diagnostics. However, it is not always suitable for some applications where detection of more than 5-6 targets is necessary. Realtime PCR has traditionally been limited to 5-6 targets because of optical physics limitation in relation to fluorophore specters and filters 20 is performed by high resolution melting of the second amplicon, which can be custom-made to allow for optimal discrimination of melting curves. However, the reaction mixture contains a significantly higher quantity of DNA sequences than other detection methods which can limit the multiplexing capabilities by creating nonspecific amplification. Faltin et al. 25 have developed a system using a 105 universal reporter comprised of an amplification probe containing a target independent sequence and a separate hairpin oligonucleotide labeled with fluorophore and quencher moieties. The sequence independent segment of the amplification probe serves as a primer for the hairpin structure. Elongation of this secondary primer causes opening of the hairpin resulting in the physical separation of the quencher and fluorophore moieties and emission of fluorescence. However, multiplexing capabilities
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are not superior to real-time PCR.
In this work, we report a new approach to perform PCR amplification and microarray hybridization in the same reaction chamber and with a single buffer. To achieve this, we have designed labeled structured oligonucleotides called SCISSOHR which adopt a particular secondary structure comprising 115 a first moiety that recognizes a specific target sequence and a second moiety that enables the specific efficient hybridization on a surface-immobilized capture probe (Fig. 1) . These SCISSOHRs are used as specific probes during PCR amplification which, upon recognition of their specific complementary sequence, trigger their irreversible structural modification. Modified SCISSOHRs hybridize to microarray capture probes exposed to the reaction medium. Multiplex detection is possible through 120 the use of multiple SCISSOHR probes and spatial localization of different capture probes on the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript 2014-09-26 microarray.
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A test capable of identifying multiple targets is an important prerequisite for pathogen detection in clinical situations where different organisms can produce serious and similar symptoms such as low 125 respiratory tract infection 3, 26 . We present a proof-of-concept multiplex amplification and hybridization assay with SCISSOHR technology for the detection of three important human respiratory viruses: influenza A (FluA) virus, influenza B (FluB) virus, and respiratory syncytial virus (RSV). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript
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Materials and methods 130
Function of SCISSOHR probes. A SCISSOHR probe is composed of three (3) main segments forming a hairpin structure (Fig. 1) . One segment, complementary (C) to the target strand, constitutes one half of the stem, while the second segment is also complementary to the target strand but forms the main loop (L) of the SCISSOHR probe. The third segment serves two functions: 1° it completes the stem part with the first segment, and 2° it contains a tag (T) sequence complementary to the 135 microarray capture probe. The tag and capture probe possess a different sequence than the target recognized by the SCISSOHR probe. Microarray hybridization is thus independent from target sequences since the SCISSOHR oligonucleotide serves as an indexing probe between aqueous phase targets and solid-support capture probes. A fluorophore and a quencher moieties are present on the SCISSOHR probe and are within FRET distance in the sequence and secondary structure 27, 28 . This 140 proximity ensures sufficient quenching in all conformations. Finally, a phosphate moiety is added at the 3'-end of T1.2 to prevent elongation 29, 30 . Figure 2 illustrates the concept of the indexing probe, as well as the use of the secondary structure when the probe is subjected to PCR reaction either containing a target ( Fig. 2A) or not (Fig. 2B ). When 
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> -6 kcal/mol for 3' interactions) and minimal primer-SCISSOHR probe interactions (ΔG > -5 kcal/mol).
The best T2 sequence could be modified manually to limit undesirable interactions. The chosen T2 sequence was submitted to BLAST to ensure that it is not significantly complementary to a sequence present in the genome of the target organism. Afterwards, the chosen SCISSOHR probe sequence was tested using Mfold 32 to confirm the folding pattern and calculate Tm and ΔG of putative secondary 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript schematic of the experimental design is shown on Fig.3 . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript
Results and discussion
To demonstrate the potential of this new technology, we first describe how the design enables the SCISSOHR probes to adopt a hairpin-like structure through specific recognition of the T1.1 and T1.2 segments to the C segment ( fig. 1) . In this conformation, the T2 segment is unavailable for microarray 275 hybridization. This secondary structure must be adopted for temperatures of at least up to 60°C so it only ever opens during thermal cycling of PCR amplifications. During elongation, the SCISSOHR probe opens and C+L segments are available for hybridization to the target DNA. It is only through specific recognition of the target DNA that the opened SCISSOHR probe will be digested, irreversibly changing its conformation so the T2 segment is freely available for hybridization onto the microarray surface at 
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Target sequences must also be considered to obtain C+L segments with sufficiently high melting temperature while being relatively short (maximum length of approximately 30 nucleotides; see Fig.   1 ). Melting temperature for the double loop hairpin must also be sufficiently high, while the Gibbs free energy must be sufficiently low to favor the closed conformation in absence of target and minimize the background noise caused by hybridization of the T2 segment from an undigested SCISSOHR probe.
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To allow more flexibility in the design, the introduction of locked nucleic acids (LNA) in the sequence should be investigated since these nucleotide analogs induce a higher Tm than the standard bases 38 .
A computer program is also under construction to automate the design of SCISSOHR probes while taking into account sequence alignments to obtain desired specificity and ubiquity. The protocol for the design of SCISSOHR probes was applied to respiratory viruses as a proof of concept, but it can be 305 easily and quickly adapted for the detection of other microbial targets. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 targets. For target-specific capture probes, statistically significant differences in fluorescence and ratios of positive assays over negative control assays of 1.8, 2.5, and 2.1 were obtained respectively for FluA, FluB, and RSV (Fig. 5) . In contrast, SCISSOHR probes and capture probes recognizing targets absent from the reaction mixture were not significantly different between positive and negative assays, except for FluA capture probes in the RSV assay. However, the ratio for this capture probe was only 370 1.23, which is under the analytical limit of detection ratio of 1.31. These results also further confirmed that the GoTaq PCR buffer is compatible with microarray hybridization. Although further work should improve the fluorescence ratio of positive assays over negative control targets by offering a more robust optical detection platform and enabling temperature control of the microarray surface until fluorescence acquisition, it is worth comparing these ratios to traditionally accepted ratios to 375 differentiate between overexpression and underexpression of genes for in expression analysis microarray. A ratio of 1.5 or more typically 2 is considered sufficient to differentiate with certainty the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 . We are confident we will reach multiplexed levels of 20 to 30 targets. However, intermolecular interactions between the SCISSOHR probes and primers will ultimately be a challenge and place an upper limit on multiplexing capabilities of the technique.
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Furthermore, since the C+L segments are relatively long (27-31-nt), it is unclear whether single nucleotide polymorphism detection will readily be achievable considering the design constraints of the SCISSOHR probes. The detection of targets possessing signature genes that are sufficiently diverging from the other targets such as is the case for respiratory viruses does seem very promising however.
The SCISSOHR technique will also need to explore its capacity to detect coinfections of viruses which
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can happen in between 11 to 20% of the time. However, some studies have shown that most of these co-infections (over 75%) are caused by adenoviruses and picornaviruses. Codetection will be tested when these viruses will be added to the assay 44 .
The sensitivity of the method remains to be tested and optimized since 10 4 copies of target DNA were used for nucleic acid amplification. Further optimization of reaction conditions is still required.
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However, a more robust detection system allowing for constant, reproducible, and stable immobilization of microarrays at a fixed distance from the source and the detector must be developed before optimization can advance. The SCISSOHR amplification and hybridization procedure is presently performed in two steps since the shape of the Zeonor subarray is modified when immersed in a liquid solution at 95°C, thus it must be added only after thermal cycling is over. There are other technologies 400 trying to integrate enzymatic amplification and microarray hybridization into single vessels such as Li et al. and Alere Technologies GmbH. However, these approaches use amplification products and capture probe sequences are thus dependent from target sequences whereas our technology allows for most of the capture probes sequences to be independent from target sequences for optimal hybridization parameters. Furthermore, these existing technologies require costly injection molds not 405 commercially available or are not resistant to PCR temperature conditions. We are aware that further collaborations with thermoplastic scientists and molding investments are necessary to fully integrate amplification and hybridization in 1 a single step reaction. With such a device, the entirety of the assay could be performed in closed tubes which reduce amplicon contamination risks.
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Drying and fluorescence acquisition. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript buffer and all other buffers is statistically significant (p-value ≤ 0.01).
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